These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 14722239)
1. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239 [TBL] [Abstract][Full Text] [Related]
2. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674 [TBL] [Abstract][Full Text] [Related]
3. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695 [TBL] [Abstract][Full Text] [Related]
4. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins]. Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans. Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188 [TBL] [Abstract][Full Text] [Related]
6. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Ling YH; Jiang JD; Holland JF; Perez-Soler R Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429 [TBL] [Abstract][Full Text] [Related]
8. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. Yang JS; Hour MJ; Huang WW; Lin KL; Kuo SC; Chung JG J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006 [TBL] [Abstract][Full Text] [Related]
9. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38. Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354 [TBL] [Abstract][Full Text] [Related]
10. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. Jiang JD; Denner L; Ling YH; Li JN; Davis A; Wang Y; Li Y; Roboz J; Wang LG; Perez-Soler R; Marcelli M; Bekesi G; Holland JF Cancer Res; 2002 Nov; 62(21):6080-8. PubMed ID: 12414632 [TBL] [Abstract][Full Text] [Related]
11. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of A-105972, an antineoplastic agent. Wu-Wong JR; Alder JD; Alder L; Burns DJ; Han EK; Credo B; Tahir SK; Dayton BD; Ewing PJ; Chiou WJ Cancer Res; 2001 Feb; 61(4):1486-92. PubMed ID: 11245455 [TBL] [Abstract][Full Text] [Related]
13. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001 [TBL] [Abstract][Full Text] [Related]
14. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221 [TBL] [Abstract][Full Text] [Related]
15. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383 [TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Zhou L; Chan WK; Xu N; Xiao K; Luo H; Luo KQ; Chang DC Life Sci; 2008 Sep; 83(11-12):394-403. PubMed ID: 18721815 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Gajate C; Barasoain I; Andreu JM; Mollinedo F Cancer Res; 2000 May; 60(10):2651-9. PubMed ID: 10825137 [TBL] [Abstract][Full Text] [Related]
18. 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Beckers T; Reissmann T; Schmidt M; Burger AM; Fiebig HH; Vanhoefer U; Pongratz H; Hufsky H; Hockemeyer J; Frieser M; Mahboobi S Cancer Res; 2002 Jun; 62(11):3113-9. PubMed ID: 12036922 [TBL] [Abstract][Full Text] [Related]
19. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. Moon EY; Lerner A Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]